Shares of Merck & Co. Inc. MRK dropped 0.02% to $96.54 Tuesday, on what proved to be an all-around mixed trading session for ...

Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield ...

Merck's (MRK) new injectable version of Keytruda aims to overcome regulatory hurdles and market challenges, offering a more ...

Merck (MRK) declared a quarterly dividend of 81c per share of the company’s common stock for Q1 of 2025. Payment will be made on January 8, ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $96.31 which represents a decrease of $-2.05 or -2.08% from the prior close of $98.36. The stock opened at $97.92 and touched a ...

Neurofibromatosis type 1 is a rare, Key Insights Given the large stake in the stock by institutions, Merck's stock price might be vulnerable to their ...

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

On Tuesday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $98.58 which represents a decrease of $-2.15 or -2.13% from the prior close of $100.73. The stock opened at $100.76 and touched ...

Merck & Co.'s board has raised the drugmaker's quarterly dividend by 5.2%, to 81 cents a share from 77 cents. The new payout, equal to $3.24 a year, represents an annual yield of about 3.37%, based on ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading ... available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked ...